Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Type 2 Diabetic Patients
100%
Glycaemia
100%
Glucagon-like
100%
Receptor Agonist
100%
Liver Fat
100%
Fat Reduction
100%
Obese Type 2 Diabetes
100%
Hepatic Fat
100%
1 Receptor
100%
Hemoglobin A1c (HbA1c)
42%
Type 2 Diabetes Mellitus (T2DM)
28%
Abdominal Adipose Tissue
28%
Relative Reduction
28%
Sulfonylurea
14%
Glycated Hemoglobin
14%
High Prevalence
14%
Weight Loss
14%
Male Patients
14%
Obesity
14%
Liver
14%
Non-alcoholic Fatty Liver Disease (NAFLD)
14%
Type 2 Diabetes Mellitus Patients
14%
Treatment Level
14%
Metformin
14%
Liraglutide
14%
Obese Patients
14%
Mechanistic Studies
14%
Human Liver
14%
Proton Magnetic Resonance Spectroscopy
14%
Hepatic Steatosis
14%
1H-MRS
14%
Total Body Weight
14%
HbA1c Reduction
14%
Exenatide
14%
Liver Lipid Metabolism
14%
Dysglycemia
14%
Body Volume
14%
Lipid Reduction
14%
Obese Type 2 Diabetes Mellitus
14%
Whole-body Magnetic Resonance Imaging (WB-MRI)
14%
DPP-IV Inhibitor
14%
Mean HbA1c
14%
Biochemistry, Genetics and Molecular Biology
Glucose Blood Level
100%
Receptor Agonists
100%
Glucagon-Like Peptide 1 Receptor
100%
Maturity Onset Diabetes of the Young
100%
Lipid
100%
Glucagon-Like Peptide-1
42%
Body Weight
28%
Glycated Hemoglobin
14%
Sulfonylurea
14%
Prevalence
14%
Lipid Metabolism
14%
Magnetic Resonance Imaging
14%
Nuclear Magnetic Resonance Spectroscopy
14%
Liraglutide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 1 Receptor Agonist
100%
Fatty Liver
100%
Maturity Onset Diabetes of the Young
100%
Lipid
100%
Hemoglobin A1c
50%
Glucagon-Like Peptide-1
37%
Glycosylated Hemoglobin
12%
Sulfonylurea
12%
Prevalence
12%
Metformin
12%
Liraglutide
12%
Dipeptidyl Peptidase IV Inhibitor
12%
Nonalcoholic Fatty Liver
12%
Exendin 4
12%
Dysglycemia
12%
Immunology and Microbiology
Glucose Blood Level
100%
Agonist
100%
Glucagon-Like Peptide-1
100%
Body Weight
40%
Prevalence
20%
Non-Alcoholic Fatty Liver Disease
20%
Adipose Tissue
20%
Nuclear Magnetic Resonance Spectroscopy
20%
Lipid Metabolism
20%
Magnetic Resonance Imaging
20%
Glycosylated Hemoglobin
20%
Pretreatment
20%